Position in HIMS
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$19,196,362
-$3,424,149 QoQ
Shares Held
553,688
-49.2% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Derivatives in HIMS
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$24,269,000
PutShares
700,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CANTOR FITZGERALD, L. P. holds $74,522,967 across 4 Drug Manufacturers - Specialty & Generic names. HIMS ranks #2 (25.8% of the industry book) .
All Filings in HIMS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,196,362 | 553,688 | Shares | Defined | 2026-08-19 | |
| 2026-06-30 | $24,269,000 | 700,000 | Put | Defined | 2026-08-19 | |
| 2026-03-31 | $16,608,000 | 800,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $22,620,511 | 1,089,620 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $39,775,750 | 1,225,000 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $47,128,451 | 1,451,446 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $50,486,472 | 890,100 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $48,700,018 | 858,604 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $5,368,695 | 107,697 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $591,000 | 20,000 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $480,453 | 16,259 | Shares | Defined | 2025-05-15 | |
| 2023-09-30 | $165,112 | 26,250 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||